Research Paper Volume 16, Issue 4 pp 3332—3349
Machine learning constructs a T cell-related signature for predicting prognosis and drug sensitivity in ovarian cancer
Figure 6. T cell-related signature (TRS)-based treatment strategy for ovarian cancer. The level of immune checkpoints (A), T cell exclusion score (B), TIDE score (C), immunophenoscore (D) in ovarian cancer patients with high and low-risk score. The risk score in CR/PR and SD/PD group and corresponding ROC curve in GSE91061 (E) and IMvigor210 (F) cohort. The OS curve in patients with high and low-risk score in GSE91061 (G) and IMvigor210 (H) cohort. *p < 0.05, **p < 0.01, ***p < 0.001.